Does SIMEPREVIR Cause Hepatocellular carcinoma? 145 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 145 reports of Hepatocellular carcinoma have been filed in association with SIMEPREVIR. This represents 2.4% of all adverse event reports for SIMEPREVIR.
145
Reports of Hepatocellular carcinoma with SIMEPREVIR
2.4%
of all SIMEPREVIR reports
28
Deaths
43
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From SIMEPREVIR?
Of the 145 reports, 28 (19.3%) resulted in death, 43 (29.7%) required hospitalization, and 5 (3.4%) were considered life-threatening.
Is Hepatocellular carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIMEPREVIR. However, 145 reports have been filed with the FAERS database.
What Other Side Effects Does SIMEPREVIR Cause?
Off label use (1,166)
Anaemia (999)
Platelet count decreased (833)
White blood cell count decreased (581)
Hepatitis c (537)
Blood bilirubin increased (467)
Drug ineffective (440)
Pyrexia (429)
Rash (388)
Haemoglobin decreased (385)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
Which SIMEPREVIR Alternatives Have Lower Hepatocellular carcinoma Risk?
SIMEPREVIR vs SIMPONI
SIMEPREVIR vs SIMVASTATIN
SIMEPREVIR vs SINGULAIR
SIMEPREVIR vs SINTILIMAB
SIMEPREVIR vs SIPONIMOD